| Product Code: ETC8460633 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Psoriasis Drugs Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Psoriasis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Myanmar Psoriasis Drugs Market - Industry Life Cycle |
3.4 Myanmar Psoriasis Drugs Market - Porter's Five Forces |
3.5 Myanmar Psoriasis Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.6 Myanmar Psoriasis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 Myanmar Psoriasis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about psoriasis and its treatment options in Myanmar |
4.2.2 Growing healthcare infrastructure and access to advanced medical treatments |
4.2.3 Rising prevalence of psoriasis cases in Myanmar due to changing lifestyles and environmental factors |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for psoriasis treatment |
4.3.2 High cost of psoriasis drugs and limited insurance coverage for such treatments in Myanmar |
4.3.3 Lack of regulatory framework or guidelines specific to psoriasis management in the country |
5 Myanmar Psoriasis Drugs Market Trends |
6 Myanmar Psoriasis Drugs Market, By Types |
6.1 Myanmar Psoriasis Drugs Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Psoriasis Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F |
6.1.3 Myanmar Psoriasis Drugs Market Revenues & Volume, By Tumor Necrosis Factor Inhibitor, 2021- 2031F |
6.1.4 Myanmar Psoriasis Drugs Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2 Myanmar Psoriasis Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Psoriasis Drugs Market Revenues & Volume, By Topicals, 2021- 2031F |
6.2.3 Myanmar Psoriasis Drugs Market Revenues & Volume, By Systemic, 2021- 2031F |
6.2.4 Myanmar Psoriasis Drugs Market Revenues & Volume, By Biologics, 2021- 2031F |
7 Myanmar Psoriasis Drugs Market Import-Export Trade Statistics |
7.1 Myanmar Psoriasis Drugs Market Export to Major Countries |
7.2 Myanmar Psoriasis Drugs Market Imports from Major Countries |
8 Myanmar Psoriasis Drugs Market Key Performance Indicators |
8.1 Average waiting time for psoriasis treatment in healthcare facilities |
8.2 Number of dermatologists specializing in psoriasis treatment per capita |
8.3 Patient adherence rate to prescribed psoriasis medication |
8.4 Percentage of psoriasis patients with access to affordable treatment options |
8.5 Rate of adoption of new psoriasis treatment modalities in Myanmar |
9 Myanmar Psoriasis Drugs Market - Opportunity Assessment |
9.1 Myanmar Psoriasis Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.2 Myanmar Psoriasis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 Myanmar Psoriasis Drugs Market - Competitive Landscape |
10.1 Myanmar Psoriasis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Myanmar Psoriasis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here